Good evening. This snapshot of stories and roundup is recommended just for you, based on your interests and reading history. | | | What to know A study in Australia found that strength training while on GLP-1 weight-loss drugs like tirzepatide boosts strength despite minimal muscle preservation. Participants who lifted weights became stronger, while those who didn't grew weaker. The study, published in Nature Medicine, suggests strength gains may stem from improved muscle coordination rather than muscle mass. Eli Lilly supplied the drug but did not fund the trial. Summary is AI-generated, newsroom-reviewed. | | | | | How was today's newsletter? | | | | | | | | |